# 68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

> **NCT05000372** · PHASE1,PHASE2 · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 24 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** 68Ga-grazytracer

## Key facts

- **NCT ID:** NCT05000372
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-22
- **Primary completion:** 2024-05-25
- **Final completion:** 2024-05-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05000372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05000372, "68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05000372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*